Synthon Manages Over 30,000 Documents With QUMAS DocCompliance

JERSEY CITY, NJ, Jun 24 (MARKET WIRE) --
QUMAS, a leading provider of regulatory compliance solutions, today
announced that Synthon, a leading specialty pharma company, has selected
QUMAS DocCompliance(TM) as its enterprise regulatory content management
system. With QUMAS DocCompliance, Synthon now has a single solution
deployed across 426 active users in 6 countries that combines document
authoring, document management and real-time collaboration in one,
integrated solution.

"Prior to the deployment of the QUMAS solution, documents were stored in
multiple locations. Additionally the sign off process for regulatory
documents was manual, which resulted in significant approval delays," said
Tieme Stoutjesdijk, Information Manager at Synthon. "With the QUMAS
solution we have all our documents in a central location and can track the
life cycle of each one. The QUMAS Solution, including the electronic
signature capability, has reduced approval cycles by as much as 70%
resulting in much faster regulatory submissions."

Deployed at major pharmaceutical, medical device and biotechnology
companies across the globe, QUMAS DocCompliance provides Advanced
Lifecycle Management for all document lifecycle phases, including Create,
Edit, Review, Approve, Distribute, and Retire. The browser-based
collaborative review and authoring ensures a secure, structured and
controlled environment for multiple and remote collaboration. The Role
Based Electronic Signatures ensure that the meaning of signatures match
user intent and the Audit Trail captures more than 270 auditable events,
which can be exported or printed for regulatory agency review.

"Now that all of their documents are created and controlled in
DocCompliance, Synthon has significantly reduced the time and effort spent
looking for existing information," said Ken Hayward, Chief Technology
Officer, for QUMAS. "The QUMAS solution also provides Synthon with a
window into the approval process since it enables users to see at which
stage their document is currently located."

About QUMAS

QUMAS is the leader in Regulatory Compliance Solutions with more than 250
customer deployments and over 15 years' experience in highly regulated
industries. For more visit www.qumas.com.

About Synthon

Synthon is a pharma company specializing in the development and production
of human generic products. With facilities in seven different countries,
the company is dedicated to research, development, production, and
licensing of high quality generic medicines. Recently, Synthon has started
activities to develop and produce biopharmaceutical products. For more
visit www.synthon.com.

MEDIA CONTACT:
Caoimhe Kiely
VP Marketing
QUMAS
+353 21 4915100
Email Contact
www.qumas.com

Copyright 2009, Market Wire, All rights reserved.

-0-